J&J Wins Mesh Case, But Slammed With $247m Penalty On Hips
The company’s Ethicon business unit was cleared on allegations a pelvic mesh product had injured a Texas woman, while a jury in a separate trial issued a $247m award to patients claiming injury from the DePuy Orthopaedics Pinnacle hip.
You may also be interested in...
The worldwide joint-replacement implants market is expected to hit $20bn by 2022, according to a new report from Meddevicetracker. The growth is driven by the rising number of elderly patients, whose natural joints have been damaged by arthritis, and the rising prevalence of chronic diseases, such as obesity and diabetes, and sport-related injuries. But a look at the market and the three largest segments – shoulder, knee and hip replacements – show that new technological advancements and improved surgical techniques are increasingly making joint replacement surgeries an option for younger people as well. Here's an overview and key insights from two orthopedic surgeons on the current market and key growth drivers and limiters.
A federal judge in Texas has signed off on a $246m award for a group of six patients who say they were injured by metal-on-metal hips made by Johnson & Johnson business unit DePuy Orthopaedics.
A Philadelphia jury awarded $57m to a woman who says she was injured by Ethicon pelvic mesh products in the fifth judgement against the company in the city’s Court of Common Pleas.